Development of Anti-TNF-A Treatment Adherence Scale: Patients with Rheumatic Disease.
Background: In recent years, there has been an increase in the use of anti-TNF-α therapies in the treatment of rheumatological diseases. Aim: The aim of this study was to develop a subcutaneous anti- TNF-α treatment adherence scale and investigate and confirm the reliability and validity of this new...
| Publicado en: | International Journal of Caring Sciences Vol. 16; no. 2; pp. 829 - 840 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
International Journal of Caring Sciences
May-Aug2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172270411&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 172270411 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17915201 B92O jtl: International Journal of Caring Sciences issn: 17915201 maglogo: N pubinfo: dt: May-Aug2023 vid: 16 iid: 2 pid: 64496 pub: International Journal of Caring Sciences artinfo: ui: 172270411 172270411 172270411 172270411 ppf: 829 ppct: 11 formats: fmt: @attributes: type: P tig: atl: Development of Anti-TNF-A Treatment Adherence Scale: Patients with Rheumatic Disease. aug: au: Ozkaraman, Ayse Uzgor, Fusun Atalay, Hatice Ozden Yasar Bilge, Nazife Sule Kasifoglu, Timucin affil: Associate Professor, Eskisehir Osmangazi University Faculty of Health Sciences, Nursing Department, Eskisehir, Turkey sug: subj: Tumor Necrosis Factor Inhibitors Immunology Instrument Construction Rheumatic Diseases Diagnosis Human Male Female Scales Methodological Research Reliability and Validity Test-Retest Reliability Factor Analysis Structural Equation Modeling Internal Consistency Coefficient alpha Funding Source Male Female ab: Background: In recent years, there has been an increase in the use of anti-TNF-α therapies in the treatment of rheumatological diseases. Aim: The aim of this study was to develop a subcutaneous anti- TNF-α treatment adherence scale and investigate and confirm the reliability and validity of this new instrument. This methodological study was performed in an university hospitals between April 2018 and March 2019. The sample of the study (n:165) consisted of individuals who were completed the first month of SC anti TNF-α treatment. The research data were collected by using an individual introduction form and the newly developed Anti TNF-α Treatment Adherence Scale. In the analysis of the data, the test-retest reliability analysis, validity analysis, factor analysis, structural equation model and internal consistency analysis were used. Results: The item-total test correlation values were determined to be between 0.33 and 0.71. In the fit index calculations, it was found that the Root Mean Square Error of Approximation was 0.10, Goodness of Fit Index was 0.999, Adjusted Goodness of Fit Index was 0.998, Comparative Fit Index was 0.926; and χ² was 2.670 (p<0.001). Cronbach α coefficient was calculated as 0.690 for factor 1, 0.765 for factor 2, 0.628 for factor 3 and 0.671 for the overall scale. Conclusion: In this study, Anti TNF-α Treatment Adherence Scale was determined that it is a valid and reliable scale. It is the first assessment tool that can be used in the evaluation of drug adherence in SC Anti-TNF-α treatment performed by patients / their relatives due to rheumatologic and all inflammatory diseases. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|